Results 101 to 110 of about 9,340 (184)

Feasibility of a 50% Dosing Interval Extension of Anti-IL-5 Biologics in Patients with Severe Asthma in Clinical Remission: A Real-World Validation Study. [PDF]

J Asthma Allergy
Vergles M, Salai G, Tudorić N, Kovačević I, Kifer D, Lalić K, Gomerčić Palčić M, Vukić Dugac A.   +7 more
europepmc   +1 more source

A Case of Eosinophilic Granulomatosis with Polyangiitis Emerging During Benralizumab Therapy: Successful Management Through a Switch to Mepolizumab Therapy. [PDF]

J Asthma Allergy
Saito Y, Ito J, Watanabe T, Tanabe Y, Sasano H, Sato Y, Jingo K, Nishimaki T, Matsuno K, Takahashi K, Harada N.   +10 more
europepmc   +1 more source

Clinical efficacy and cost-effectiveness of mepolizumab for COPD with type 2 inflammation. [PDF]

BMC Pulm Med
Buendía JA, Guerrero Patiño D, Muñoz Mejia O, Celis Preciado C.   +3 more
europepmc   +1 more source

Biologic Therapies: A Systematic Review of the Indications, Efficacy, Safety, and Outcomes in Ear, Nose, and Throat Diseases. [PDF]

Cureus
Al Saloom Z, Alawainati M, Abdeen Z, Qadmi I, Mandeel A, AlAani K.   +5 more
europepmc   +1 more source

Clinical Impact of Mepolizumab on Airway Mucus Plugs in Patients with Severe Asthma. [PDF]

J Asthma Allergy
Hara Y, Tanabe N, Marumo S, Murohashi K, Hayashi Y, Nagata M, Asada T, Nagaoka S, Kobayashi N, Hirai T, Kaneko T.   +10 more
europepmc   +1 more source

Protocol for an open labelled observational study in children & adolescents with severe asthma with an eosinophilic phenotype treated with mepolizumab (CASAM). [PDF]

PLoS One
Gupta A, de Mir Messa I, Valverde-Molina J, Murray CS, Moral L, Torres Borrego J, Pike K, Díaz-Izquierdo A, Martínez-Cañavate A, Nagakumar P, Cook J, Gupta L, CASAM Group.   +12 more
europepmc   +1 more source

Understanding Biologics in CRSwNP: Related Events and Insights. [PDF]

Curr Allergy Asthma Rep
Izquierdo-Domínguez A, Al-Salloom Z, Viñas M, Mullol J, Alobid I.   +4 more
europepmc   +1 more source

Effectiveness of Mepolizumab in Severe Uncontrolled Asthma Associated or Not with EGPA Based on the Exacto Scale and Separ-Remas Criteria. [PDF]

J Asthma Allergy
Leon Lloreda A, Muñoz-Sánchez B, Echavarria Kashmiri D, Polonio Gonzalez ML, Maestre Sanchez MV, Ferrrer Galvan M, Romero Falcon A, Medina Gallardo JF, Alvarez-Gutierrez FJ.   +8 more
europepmc   +1 more source

Correction: Dupilumab Versus Mepolizumab for COPD: Evaluating Efficacy Outcomes Using Placebo-Adjusted Indirect Treatment Comparison. [PDF]

Pulm Ther
Bhatt SP, Freemantle N, Soliman M, Heble J, Cabon Y, Mayen Herrera E, Yang J, Xu Y.   +7 more
europepmc   +1 more source

The Therapeutic Role of Biologics in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP): A Review of the Current Evidence. [PDF]

Ther Clin Risk Manag
Chen W, Wen Y, Wang J, Meng X, Su L, Wu Y.   +5 more
europepmc   +1 more source